Jul 62 min readLabGenius Lands £35M in Series B Funding to Revolutionize Therapeutic Antibody DiscoveryLabGenius, a trailblazing drug discovery firm harnessing machine learning to unearth novel therapeutic antibodies, has secured £35...
.png)
